MOS vs SER · P/E 161, rev $11.12B vs rev $56.0K
The Mosaic Company (MOS) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. SER currently screens at market cap $29.7M.
Not investment advice. Open the MOS and SER stock pages for the full models.
Not investment advice.